Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TRAM2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | FANCF | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SRPK1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TOP2B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SGCD | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ASB14 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ARMC9 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | CCDC168 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CCDC177 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |